Profile
Tanya Fischer, formerly Head of Translational Medicine at Alnylam Pharmaceuticals, Inc., and Associate Professor at Yale University, also served as the Chief Development Officer at Biohaven Ltd.
from 2022 to 2023.
Former positions of Tanya Fischer
| Companies | Position | End |
|---|---|---|
| BIOHAVEN LTD. | Corporate Officer/Principal | 2023-09-30 |
| Yale University | Corporate Officer/Principal | - |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
3
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| BIOHAVEN LTD. | Health Technology |
- Stock Market
- Insiders
- Tanya Fischer
